Romani, IT
Aldo Romani, Rimini IT
Patent application number | Description | Published |
---|---|---|
20110018264 | ENERGY CONVERSION AND ACCUMULATION DEVICE AND RELATIVE METHOD - An energy conversion and accumulation device, for the conversion of environmental energy into electric energy, includes a transducer, able to convert external environmental stress into an electric quantity, a storage element to accumulate and/or transfer the electric quantity to an electric device, a first switch element, activated in order to transfer electric energy from the transducer directly to a temporary storage element, and a second switch element activated in order to transfer electric energy stored by the temporary storage element directly to the storage element. The device further includes a sensor element, associated with the transducer, temporary storage element, and storage element. The sensor element detects predetermined energy conditions favorable for the selective and/or mutually alternate activation of the switch elements for a corresponding alternate electric energy transfer respectively from the transducer to the temporary storage element and from the temporary storage element to the storage element. | 01-27-2011 |
Aldo Romani, Lugo IT
Patent application number | Description | Published |
---|---|---|
20130333454 | PROCESS AND APPARATUS FOR THE MEASUREMENT OF THE HARDNESS AND FOR THE SELECTION OF AGRICULTURAL PRODUCTS - Method for measuring the hardness of agricultural products includes: implementing a test program suitable for identifying and selecting one or more indices (S3, S4) which can be measured with a non-destructive test on a respective product/fruit, correlated with the hardness (Du) of the same product/fruit, measured by a respective penetration test; and calculating the coefficients that define the straight line representative of the linear correlation between said indices and the hardness for the respective product. The method is implemented with the operations of: applying on the product a dynamic force, preferably of impulsive type; detecting the mechanical reaction through at least a piezoelectric transducer capable of generating an electric signal based on the application or transmission of said dynamic force through the respective kiwi fruit; and analyzing said electric signal relative to the fruit. | 12-19-2013 |
Annalisa Romani, S. Michele Agliana IT
Patent application number | Description | Published |
---|---|---|
20100055211 | PROCESS FOR PRODUCING REFINED NUTRACEUTIC EXTRACTS FROM ARTICHOKE WASTE AND FROM OTHER PLANTS OF THE CYNARA GENUS - Process for fractioning and refining natural products obtainable from waste vegetal material and particularly from artichoke ( | 03-04-2010 |
20130131328 | PROCESS FOR PRODUCING REFINED NUTRACEUTIC EXTRACTS FROM ARTICHOKE WASTE AND FROM OTHER PLANTS OF THE CYNARA GENUS - Process for fractioning and refining natural products obtainable from waste vegetal material and particularly from artichoke ( | 05-23-2013 |
Annalisa Romani, San Michele Agliana (pt) IT
Patent application number | Description | Published |
---|---|---|
20150208719 | METHOD FOR MAKING LOW NITROSAMINE CONTENTS TOBACCO - A method for making tobacco provides to use chestnut ( | 07-30-2015 |
20150223512 | USE OF CHESTNUT TANNINS EXTRACT AS ANTI-OXIDANT, ANTI-MICROBIAL ADDITIVE AND TO REDUCE NITROSAMINES AND MYCOTOXINS - The use is described of chestnut tannin extract ( | 08-13-2015 |
Annalisa Romani, S. Michele Agliana Pt IT
Patent application number | Description | Published |
---|---|---|
20130131328 | PROCESS FOR PRODUCING REFINED NUTRACEUTIC EXTRACTS FROM ARTICHOKE WASTE AND FROM OTHER PLANTS OF THE CYNARA GENUS - Process for fractioning and refining natural products obtainable from waste vegetal material and particularly from artichoke ( | 05-23-2013 |
Antonello Romani, Parma IT
Patent application number | Description | Published |
---|---|---|
20160083427 | CYCLIC CATIONIC PEPTIDES WITH ANTIBMICROBIAL ACTIVITY - A series of cationic cyclic peptides, useful for the treatment of infectious diseases in both human and veterinary clinical/surgical environment are described herein. The peptides of the invention have a length of 15 to 21 amino acids, and show a sequence A-B-C-D-C′-B′-A′, wherein units A and A′ correspond to —NH | 03-24-2016 |
Carlo Alberto Romani, Cornaredo IT
Patent application number | Description | Published |
---|---|---|
20100164585 | SEMICONDUCTOR DEVICE WITH INTEGRATED DELAY CHAIN - A semiconductor device wherein a delay chain is integrated; the semiconductor device having a semiconductor layer. The delay chain includes a plurality of delay cells placed in the semiconductor layer and electrically connected to each other so as to form the delay chain. The semiconductor device includes a first and second metal lines respectively connected to a supply voltage and a reference voltage and placed in a longitudinal direction on a surface of the semiconductor layer; each delay cell of the plurality of cells is electrically connected with the first and second metal lines. Any delay cell and its successive or preceding delay cells of the delay chain are placed in a transversal direction with respect to the first or the second metal line. | 07-01-2010 |
20120153936 | READING CIRCUIT FOR A MAGNETIC FIELD SENSOR WITH SENSITIVITY CALIBRATION, AND RELATED READING METHOD - A reading circuit for a magnetic-field sensor, generating an electrical detection quantity as a function of a detected magnetic field and of a detection sensitivity, is provided with an amplification stage, which is coupled to the magnetic-field sensor and generates an output signal as a function of the electrical detection quantity and of an amplification gain. In particular, the amplification gain is electronically selectable, and the reading circuit is moreover provided with a calibration stage, integrated with the amplification stage and configured so as to vary a value of the amplification gain in such a way as to compensate a variation of the detection sensitivity with respect to a nominal sensitivity value. | 06-21-2012 |
20120153937 | BIASING CIRCUIT FOR A MAGNETIC FIELD SENSOR, AND CORRESPONDING BIASING METHOD - Described herein is a biasing circuit for a magnetic-field sensor; the magnetic-field sensor is provided with a first detection structure, which generates a first electrical detection quantity as a function of a first component of an external magnetic field, and a second detection structure, which generates a second electrical detection quantity as a function of a second component of an external magnetic field. The biasing circuit electrically supplies the first detection structure and the second detection structure in respective biasing time intervals, at least partially distinct from one another, which preferably do not temporally overlap one other. | 06-21-2012 |
20120158324 | MAGNETIC SENSOR READING DEVICE, SYSTEM AND METHOD - A reading circuit for a magnetic-field sensor, provided with a detection structure generating an electrical detection signal as a function of an external magnetic field, has a signal-conditioning stage, which is electrically coupled to the detection structure and generates an output signal as a function of the electrical detection signal; the reading circuit is provided with a full-scale-control stage that is able to select automatically a full-scale value for the signal-conditioning stage, as a function of the value of the external magnetic field, such as to prevent saturation of the same conditioning stage. | 06-21-2012 |
20120161759 | MAGNETORESISTIVE SENSOR WITH REDUCED PARASITIC CAPACITANCE, AND METHOD - A magnetic-field sensor adapted to detect an external magnetic field, comprising: a first chip, including a first magnetoresistive structure for detection of the external magnetic field, the first magnetoresistive detection structure including an electrical-contact pad and magnetoresistive means; and a second chip housing an integrated electronic circuit and a magnetic-field generator, the first and second chips being mutually arranged in such a way that the integrated electronic circuit can be electrically coupled to the electrical-contact pad of the magnetoresistive structure and in such a way that the magnetic-field generator can be magnetically coupled to the magnetoresistive structure. | 06-28-2012 |
20120166122 | READING CIRCUIT WITH AUTOMATIC OFFSET COMPENSATION FOR A MAGNETIC-FIELD SENSOR, AND RELATED READING METHOD WITH AUTOMATIC OFFSET COMPENSATION - A method for reading a magnetic-field sensor provided with at least one first magnetoresistive element envisages generation of an output signal, indicative of a magnetic field, as a function of a detection signal supplied by the magnetic-field sensor. The reading method envisages: determining an offset signal present in the output signal; generating at least one compensation quantity as a function of the offset signal; and feeding back the compensation quantity at input to the reading stage so as to apply a corrective factor at input to the reading stage as a function of the compensation quantity, such as to reduce the value of the offset signal below a given threshold. | 06-28-2012 |
20150192644 | READING CIRCUIT FOR A MAGNETIC FIELD SENSOR WITH SENSITIVITY CALIBRATION, AND RELATED READING METHOD - A reading circuit for a magnetic-field sensor, generating an electrical detection quantity as a function of a detected magnetic field and of a detection sensitivity, is provided with an amplification stage, which is coupled to the magnetic-field sensor and generates an output signal as a function of the electrical detection quantity and of an amplification gain. In particular, the amplification gain is electronically selectable, and the reading circuit is moreover provided with a calibration stage, integrated with the amplification stage and configured so as to vary a value of the amplification gain in such a way as to compensate a variation of the detection sensitivity with respect to a nominal sensitivity value. | 07-09-2015 |
20150198680 | BIASING CIRCUIT FOR A MAGNETIC FIELD SENSOR, AND CORRESPONDING BIASING METHOD - Described herein is a biasing circuit for a magnetic-field sensor; the magnetic-field sensor is provided with a first detection structure, which generates a first electrical detection quantity as a function of a first component of an external magnetic field, and a second detection structure, which generates a second electrical detection quantity as a function of a second component of an external magnetic field. The biasing circuit electrically supplies the first detection structure and the second detection structure in respective biasing time intervals, at least partially distinct from one another, which preferably do not temporally overlap one other. | 07-16-2015 |
20150362563 | READING CIRCUIT FOR A MAGNETIC FIELD SENSOR WITH SENSITITIVY CALIBRATION, AND RELATED READING METHOD - A reading circuit for a magnetic-field sensor, generating an electrical detection quantity as a function of a detected magnetic field and of a detection sensitivity, is provided with an amplification stage, which is coupled to the magnetic-field sensor and generates an output signal as a function of the electrical detection quantity. In particular, the reading circuit is provided with a calibration stage, integrated with the amplification stage and configured so as to control a feedback loop in such a way as to compensate a variation of the detection sensitivity with respect to a nominal sensitivity value. | 12-17-2015 |
Edoardo Romani, San Gemini IT
Patent application number | Description | Published |
---|---|---|
20160045520 | USE IN ONE PILL TABLET CAPSULE MINOCYCLINE ACYCLOGUANOSINE ATORVASTATIN AND VITAMIN D3 IN THE TREATMENT OF RHEUMATOID ARTHRITIS - The present invention has for object the use of minocycline or its equivalent forms, or any form of tetracycline in combination with acycloguanosine or any equivalent form (antiviral), atorvastatin or any equivalent form (lipophilic statins) and vitamin D3 (pro hormone) for the preparation of a single compound addressed to treatment of autoimmune type of rheumatoid arthritis in the three stages of development, whether it is active or quiescent phase or forms of diseases eziopatologicamente equivalent, but some degenerative. The efficacy of this combination has been proven by many studies on individual components. To date, given the proven effectiveness of the individual components, the low toxicity of the same and the long period of their marketing, as well as the observed higher efficiency of the combination of these used in accordance with the new mode overexposed, it can be said that the new compound abovementioned derived from a combination of minocycline or its equivalent forms, or any form of tetracycline in combination with acycloguanosine or any equivalent form (antiviral), atorvastatin or any equivalent form (lipophilic statins) and vitamin D3 (pro-hormone), is effective in reducing the incidence of the disease on quality of life of the patient, in particular with a certain dose level, before today never identified or determined. | 02-18-2016 |
Edoardo Romani, San Gemini (tr) IT
Patent application number | Description | Published |
---|---|---|
20160045520 | USE IN ONE PILL TABLET CAPSULE MINOCYCLINE ACYCLOGUANOSINE ATORVASTATIN AND VITAMIN D3 IN THE TREATMENT OF RHEUMATOID ARTHRITIS - The present invention has for object the use of minocycline or its equivalent forms, or any form of tetracycline in combination with acycloguanosine or any equivalent form (antiviral), atorvastatin or any equivalent form (lipophilic statins) and vitamin D3 (pro hormone) for the preparation of a single compound addressed to treatment of autoimmune type of rheumatoid arthritis in the three stages of development, whether it is active or quiescent phase or forms of diseases eziopatologicamente equivalent, but some degenerative. The efficacy of this combination has been proven by many studies on individual components. To date, given the proven effectiveness of the individual components, the low toxicity of the same and the long period of their marketing, as well as the observed higher efficiency of the combination of these used in accordance with the new mode overexposed, it can be said that the new compound abovementioned derived from a combination of minocycline or its equivalent forms, or any form of tetracycline in combination with acycloguanosine or any equivalent form (antiviral), atorvastatin or any equivalent form (lipophilic statins) and vitamin D3 (pro-hormone), is effective in reducing the incidence of the disease on quality of life of the patient, in particular with a certain dose level, before today never identified or determined. | 02-18-2016 |
Francesco Romani, Pisa IT
Patent application number | Description | Published |
---|---|---|
20120317041 | Patent Value Calculation - Techniques for calculating patent value and predicting patent potential are described herein. These techniques may include calculating the value of a patent based on associations between a patent and other patents. The value of the patent may be calculated based on a citation in another patent to the patent, and a citation in the patent to a further patent. These techniques may also include predicting a potential value of a patent on the basis of a plurality of patent values and displaying this potential to a user. | 12-13-2012 |
Francesco Romani, Milano IT
Patent application number | Description | Published |
---|---|---|
20080251174 | Pneumatic Tyre - A pneumatic tyre includes: a carcass structure with at least one carcass ply shaped in a substantially toroidal configuration, the opposite lateral edges of which are associated with respective right-hand and left-hand bead wires, each bead wire being enclosed in a respective bead, a belt structure including at least one belt layer applied in a circumferentially external position relative to the carcass structure; a tread band superimposed circumferentially on the belt structure including a radially outer layer designed to come into contact with the ground; and a pair of sidewalls applied laterally on opposite sides relative to the carcass structure. The tread band includes an elastomeric material obtained by cross-linking a cross-linkable elastomeric composition including: a) from 15 phr to 95 phr of at least one styrene-butadiene rubber; b) from 5 phr to 30 phr of at least one halogenated butyl rubber; c) from 0 phr to 60 phr of at least one diene rubber other than a); d) from 0.3 phr to 3.5 phr of at least one aminosilane containing at least one hydroxy group or hydrolysable group attached to the silicon atom of the silane; e) from 10 phr to 140 phr of at least one silica filler; and f) from 0.5 phr to 25 phr of at least one sulphur-containing silane with at least one hydroxy group or hydrolysable group attached to the silicon atom of the silane. | 10-16-2008 |
20090056847 | STUDDED TIRE - A tire for vehicle a wheel includes a carcass structure including at least one carcass ply shaped in a substantially toroidal configuration, the opposite lateral edges of which are associated with respective right-hand and left-hand bead wires enclosed in respective beads; a belt structure applied in a circumferentially external position relative to the carcass structure; a tread band circumferentially superimposed on the belt structure, the tread band including a radially outer surface with a tread pattern including a plurality of longitudinal and transverse grooves which define a corresponding plurality of blocks and/or ribs; a plurality of studs partially projecting from the radially outer surface of the tread band; and a pair of side walls applied laterally on opposite sides relative to the carcass structure. The tread band includes a crosslinked elastomeric composition including at least one diene elastomeric polymer and at least one layered nanosized inorganic material as reinforcing filler. | 03-05-2009 |
Gianni Romani, Terni IT
Patent application number | Description | Published |
---|---|---|
20140322466 | MICROFIBROUS PRODUCT AND THE USE THEREOF FOR THE PREPARATION OF COVERS AND CASES - The invention refers to a process for the preparation of a microfibrous non-woven fabric based on polyester or polyamide microfibres immersed in a polyurethane matrix, and having a thickness equal to or less than 0.65 mm, a flat or slightly mottled appearance and a nap length of less than 350 μm. The non-woven fabric is used for the preparation of coverings for consumer goods, particularly for the preparation of covers and cases for electronic products. | 10-30-2014 |
20150275421 | PROCESS FOR THE PREPARATION OF A NON-WOVEN MICROFIBROUS SUEDE-LIKE SYNTHETIC FABRIC - The present invention refers to a process for the preparation of a non-woven microfibrous suede-like synthetic fabric that does not require the use of organic solvents and that makes it possible to obtain a finished product offering a good hand, excellent resistance to yellowing and high durability. It comprises needle-punching a felt of sea/island fibres, (a) impregnation with hot aqueous solution of PVOH having a degree of saponification of at least 94% or (b) impregnation with hot water followed by impregnation with cold PUR, removing the sea component, impregnating with PUR, coagulating the PUR, removing the PVOH, grinding the surface, dyeing and splitting in two sheets. | 10-01-2015 |
Luigina Romani, Perugia (pg) IT
Patent application number | Description | Published |
---|---|---|
20140296135 | MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS - The combination of pentraxin PTX3 with antifungals is described for the treatment of fungal infections and particularly for infections caused by | 10-02-2014 |
Luigina Romani, Perugia IT
Patent application number | Description | Published |
---|---|---|
20090155260 | USE OF THYMOSIN ALPHA 1 FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES - It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin. | 06-18-2009 |
20090270594 | USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ALLERGIES - The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies | 10-29-2009 |
20090275508 | USE OF THYMOSIN ALPHA 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION - It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation. | 11-05-2009 |
20090286726 | USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES - It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation. | 11-19-2009 |
20100004174 | USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES - The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases such as multiple sclerosis, and inflammatory bowel diseases such as Crohn's disease or ulcerative colitis. | 01-07-2010 |
20100291084 | USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION - Methods and compositions comprising antagonists of IL-23 are provided for the treatment of infections, such as chronic bacterial, viral and fungal infections. | 11-18-2010 |
20110224132 | USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES - It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation. | 09-15-2011 |
20120295840 | TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES - A method for treating a human infected with | 11-22-2012 |
20140147442 | USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION - Methods and compositions comprising antagonists of IL-23 are provided for the treatment of infections, such as chronic bacterial, viral and fungal infections. | 05-29-2014 |
Romano Romani, Felino IT
Patent application number | Description | Published |
---|---|---|
20100049104 | DEVICE FOR THE TREATMENT OF TINNITUS - A device for the treatment of tinnitus, comprising generator means able to generate an audio signal, and transducer means connected to the generator means in order to reproduce the audio signal. The device also comprises filter means interposed between the generator means and the transducer means in order to filter and substantially suppress the audio signal at least in correspondence with an interval of frequencies around the dominant frequency (Ft) of tinnitus, so as to obtain a silent window (silent band) having a selected width or amplitude around said dominant frequency (Ft) of tinnitus. | 02-25-2010 |
Stefano Romani, Roma IT
Patent application number | Description | Published |
---|---|---|
20110122031 | Radio Device for a Wireless Network - A radio device for a wireless network comprising: an outer protective casing housing an electronic transceiver circuit; and four radiating elements carried by the protective casing and having orientations that differ from one another. The outer protective casing is configured in such a way that, when it is set on a plane surface, it sets itself with just one radiating element substantially perpendicular to the plane surface; the radio device is able to determine autonomously the orientation assumed and comprises an automatic selector for selecting the radiating element set substantially perpendicular to the plane surface. | 05-26-2011 |